Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Buy
53
AFJK Quote, Financials, Valuation and Earnings
Last price:
$57.59
Seasonality move
:
2.33%
Day range:
$46.82 - $53.35
52-week range:
$6.75 - $130.37
Dividend yield:
0%
P/E ratio:
232.36x
P/S ratio:
--
P/B ratio:
6.82x
Volume:
26.6K
Avg. volume:
427.8K
1-year change:
335.53%
Market cap:
$286.6M
Revenue:
--
EPS (TTM):
$0.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
-- | -- | -- | -- | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | -- | -- | -- | -- |
|
CCAP
Crescent Capital BDC, Inc.
|
$39.8M | $0.43 | -9.28% | 59.5% | $16.08 |
|
GRAF
Graf Global Corp.
|
-- | -- | -- | -- | -- |
|
LEGT
Legato Merger Corp. III
|
-- | -- | -- | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
$46.82 | -- | $286.6M | 232.36x | $0.00 | 0% | -- |
|
ATMC
AlphaTime Acquisition Corp.
|
$15.60 | -- | $39.8M | 152.05x | $0.00 | 0% | -- |
|
CCAP
Crescent Capital BDC, Inc.
|
$14.42 | $16.08 | $533.4M | 14.84x | $0.42 | 11.65% | 3.42x |
|
GRAF
Graf Global Corp.
|
$10.71 | -- | $307.9M | 35.52x | $0.00 | 0% | -- |
|
LEGT
Legato Merger Corp. III
|
$10.91 | -- | $281.5M | 32.97x | $0.00 | 0% | -- |
|
TBMC
Trailblazer Merger Corp. I
|
$12.46 | -- | $30.6M | 266.34x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
3.79% | -6.107 | 2.39% | 0.00x |
|
ATMC
AlphaTime Acquisition Corp.
|
11.55% | -0.079 | 3.42% | 0.00x |
|
CCAP
Crescent Capital BDC, Inc.
|
55.07% | 0.171 | 168.67% | 3.38x |
|
GRAF
Graf Global Corp.
|
-- | 0.025 | -- | 0.00x |
|
LEGT
Legato Merger Corp. III
|
-- | -0.032 | -- | -- |
|
TBMC
Trailblazer Merger Corp. I
|
-1177.47% | -0.278 | 25.81% | 0.70x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AFJK
Aimei Health Technology Co., Ltd.
|
-- | -$130.2K | 2.58% | 2.61% | -- | -$96.1K |
|
ATMC
AlphaTime Acquisition Corp.
|
-- | $1.5K | 2.28% | 2.45% | -- | $60.9K |
|
CCAP
Crescent Capital BDC, Inc.
|
$27.8M | $21.4M | 2.24% | 4.93% | 58.62% | $18.7M |
|
GRAF
Graf Global Corp.
|
-- | -$798.2K | 3.79% | 3.79% | -- | -$106.5K |
|
LEGT
Legato Merger Corp. III
|
-- | -$269.1K | 4.1% | 4.1% | -- | -$212.1K |
|
TBMC
Trailblazer Merger Corp. I
|
-- | -$563.8K | -26.31% | -32.93% | -- | -$1.4M |
Aimei Health Technology Co., Ltd. vs. Competitors
-
Which has Higher Returns AFJK or ATMC?
AlphaTime Acquisition Corp. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat AlphaTime Acquisition Corp.'s return on equity of 2.45%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M ATMCAlphaTime Acquisition Corp.-- $0.06 $13.3M -
What do Analysts Say About AFJK or ATMC?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand AlphaTime Acquisition Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than AlphaTime Acquisition Corp., analysts believe Aimei Health Technology Co., Ltd. is more attractive than AlphaTime Acquisition Corp..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 ATMCAlphaTime Acquisition Corp.0 0 0 -
Is AFJK or ATMC More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison AlphaTime Acquisition Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or ATMC?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AlphaTime Acquisition Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. AlphaTime Acquisition Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or ATMC?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than AlphaTime Acquisition Corp. quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is higher than AlphaTime Acquisition Corp.'s net income of $202.1K. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 232.36x while AlphaTime Acquisition Corp.'s PE ratio is 152.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for AlphaTime Acquisition Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 232.36x -- $352K ATMCAlphaTime Acquisition Corp.-- 152.05x -- $202.1K
-
Which has Higher Returns AFJK or CCAP?
Crescent Capital BDC, Inc. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of 19.49%. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Crescent Capital BDC, Inc.'s return on equity of 4.93%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M CCAPCrescent Capital BDC, Inc.76.15% $0.19 $1.6B -
What do Analysts Say About AFJK or CCAP?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Crescent Capital BDC, Inc. has an analysts' consensus of $16.08 which suggests that it could grow by 11.54%. Given that Crescent Capital BDC, Inc. has higher upside potential than Aimei Health Technology Co., Ltd., analysts believe Crescent Capital BDC, Inc. is more attractive than Aimei Health Technology Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 CCAPCrescent Capital BDC, Inc.3 1 0 -
Is AFJK or CCAP More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Crescent Capital BDC, Inc. has a beta of 0.547, suggesting its less volatile than the S&P 500 by 45.283%.
-
Which is a Better Dividend Stock AFJK or CCAP?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Crescent Capital BDC, Inc. offers a yield of 11.65% to investors and pays a quarterly dividend of $0.42 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Crescent Capital BDC, Inc. pays out 84.04% of its earnings as a dividend. Crescent Capital BDC, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AFJK or CCAP?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Crescent Capital BDC, Inc. quarterly revenues of $36.4M. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Crescent Capital BDC, Inc.'s net income of $7.1M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 232.36x while Crescent Capital BDC, Inc.'s PE ratio is 14.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus 3.42x for Crescent Capital BDC, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 232.36x -- $352K CCAPCrescent Capital BDC, Inc.3.42x 14.84x $36.4M $7.1M
-
Which has Higher Returns AFJK or GRAF?
Graf Global Corp. has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Graf Global Corp.'s return on equity of 3.79%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M GRAFGraf Global Corp.-- $0.06 $232.8M -
What do Analysts Say About AFJK or GRAF?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Graf Global Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Graf Global Corp., analysts believe Aimei Health Technology Co., Ltd. is more attractive than Graf Global Corp..
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 GRAFGraf Global Corp.0 0 0 -
Is AFJK or GRAF More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Graf Global Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or GRAF?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Graf Global Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Graf Global Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or GRAF?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Graf Global Corp. quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Graf Global Corp.'s net income of $1.7M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 232.36x while Graf Global Corp.'s PE ratio is 35.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Graf Global Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 232.36x -- $352K GRAFGraf Global Corp.-- 35.52x -- $1.7M
-
Which has Higher Returns AFJK or LEGT?
Legato Merger Corp. III has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Legato Merger Corp. III's return on equity of 4.1%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M LEGTLegato Merger Corp. III-- $0.08 $210.9M -
What do Analysts Say About AFJK or LEGT?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Legato Merger Corp. III has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Legato Merger Corp. III, analysts believe Aimei Health Technology Co., Ltd. is more attractive than Legato Merger Corp. III.
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 LEGTLegato Merger Corp. III0 0 0 -
Is AFJK or LEGT More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Legato Merger Corp. III has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or LEGT?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Legato Merger Corp. III offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Legato Merger Corp. III pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or LEGT?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Legato Merger Corp. III quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is lower than Legato Merger Corp. III's net income of $2M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 232.36x while Legato Merger Corp. III's PE ratio is 32.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Legato Merger Corp. III. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 232.36x -- $352K LEGTLegato Merger Corp. III-- 32.97x -- $2M
-
Which has Higher Returns AFJK or TBMC?
Trailblazer Merger Corp. I has a net margin of -- compared to Aimei Health Technology Co., Ltd.'s net margin of --. Aimei Health Technology Co., Ltd.'s return on equity of 2.61% beat Trailblazer Merger Corp. I's return on equity of -32.93%.
Company Gross Margin Earnings Per Share Invested Capital AFJKAimei Health Technology Co., Ltd.-- $0.06 $43.7M TBMCTrailblazer Merger Corp. I-- -$0.82 -$627.9K -
What do Analysts Say About AFJK or TBMC?
Aimei Health Technology Co., Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Trailblazer Merger Corp. I has an analysts' consensus of -- which suggests that it could fall by --. Given that Aimei Health Technology Co., Ltd. has higher upside potential than Trailblazer Merger Corp. I, analysts believe Aimei Health Technology Co., Ltd. is more attractive than Trailblazer Merger Corp. I.
Company Buy Ratings Hold Ratings Sell Ratings AFJKAimei Health Technology Co., Ltd.0 0 0 TBMCTrailblazer Merger Corp. I0 0 0 -
Is AFJK or TBMC More Risky?
Aimei Health Technology Co., Ltd. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Trailblazer Merger Corp. I has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AFJK or TBMC?
Aimei Health Technology Co., Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Trailblazer Merger Corp. I offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aimei Health Technology Co., Ltd. pays -- of its earnings as a dividend. Trailblazer Merger Corp. I pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AFJK or TBMC?
Aimei Health Technology Co., Ltd. quarterly revenues are --, which are smaller than Trailblazer Merger Corp. I quarterly revenues of --. Aimei Health Technology Co., Ltd.'s net income of $352K is higher than Trailblazer Merger Corp. I's net income of -$3.7M. Notably, Aimei Health Technology Co., Ltd.'s price-to-earnings ratio is 232.36x while Trailblazer Merger Corp. I's PE ratio is 266.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aimei Health Technology Co., Ltd. is -- versus -- for Trailblazer Merger Corp. I. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AFJKAimei Health Technology Co., Ltd.-- 232.36x -- $352K TBMCTrailblazer Merger Corp. I-- 266.34x -- -$3.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 61x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Sell
42
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
70
RAPT alert for Jan 21
Rapt Therapeutics, Inc. [RAPT] is up 0.05% over the past day.
Buy
73
HYMC alert for Jan 21
Hycroft Mining Holding Corp. [HYMC] is down 7.55% over the past day.
Buy
92
GMINF alert for Jan 21
G Mining Ventures Corp. [GMINF] is down 0.81% over the past day.
